Effect of dalfamprine on spatiotemporal gait parameters in multiple sclerosis  by Abadie, L. et al.
Multiple sclerosis
Oral communications
CO26-002-e
Epidemiology of self-reported
multiple sclerosis in the French adult
population: A transversal study
A. Charlanes a,*, C. Jourdan (Dr)b, L. Josserand (Dr)c,
P. Azouvi (Prof)b, F. Geneˆt (Prof)b,
A. Schnitzler (Dr)b
a Service de me´decine physique et de re´adaptation, hoˆpital Raymond-
Poincare´, AP–HP, Garches, France
b Service de me´decine physique et de re´adaptation, hoˆpital Raymond-
Poincare´, AP–HP, universite´ de Versailles Saint-Quentin (HANDIReSP),
Garches, France
c E´pide´miologie, hoˆpital Raymond-Poincare´, AP–HP, universite´ de
Versailles Saint-Quentin (HANDIReSP), Garches, France
*Corresponding author.
E-mail address: audreycharlanes@gmail.com (A. Charlanes)
Objectives In France, the epidemiology of multiple sclerosis and its
functional consequences are little known. This study aims to describe
prevalence and consequences of MS in the French Population.
Methods Two large population-based surveys ‘‘Disability health
household’’ and ‘‘Disability health institutions’’ interviewed
individuals living in France. Information about medical conditions,
impairments, disabilities, and participation restriction was col-
lected. Participants reporting multiple sclerosis as medical
condition were speciﬁcally analyzed. Through sampling and
weighted analysis of 33,896 structured interviews, 49,028,826
individuals living in France were represented.
Results The study showed a prevalence of self-reported MS of
211.8/100,000 (CI95% 157.5–266.1). The sex ratio was 2.91 (CI95%
1.85–4.57) women for one man. A north/south gradient did not
appear. Mean age was 52 years (SD 1.37). Participants who
declaredMS reported fatigue for 86.8% (IC95% 79.8–95.8), mobility
impairments for 75.9% (IC95% 65.8–86.1) and balance disorders for
65.6% (IC95% 54.6–76.7). Rates were respectively 44.9% (IC95% 44–
45.9), 11% (IC95% 10.6–11.5) and 6.4% (IC95% 6.1–6.7) for subjects
who did not report MS. Regarding difﬁculties in carrying out
activities of daily living, 24.8% of MS subjects were dependant for
washing, 17.3% for transfers, 12% for continence and 7.3% for
feeding. 68.9% of subjects had an EDSS score below or equal to 4
and 7.9% higher or equal to 7.5.
Discussion Our study showed a higher prevalence of multiple
sclerosis in France than previous French estimations did (between
60 and 142/100,000). Recent studies completed in other European
countries resulted in similar results. This strengthens the
hypothesis that prevalence of MS has increased. Improvements
in diagnosis of MS and the declarative method of the survey might
partly explain this higher prevalence ﬁgure. However, further
studies would be required to document and explain the increased
prevalence of this pathology, which has heavy functional
consequences.
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Objective Improvement of spatiotemporal gait parameters with
dalfampridine.
Method Retrospective study of data collected prospectively in
patients with multiple sclerosis treated by dalfampridine for gait
disorders. Spatiotemporal gait parameters [1] were measured
using a locometer at spontaneous and supported velocity after the
establishment of dalfambridine and after 14 days of treatment. In
addition, a clinical examination and Time 25 Foot Walk Test
(T25FW) were executed.
Results Two hundred patients with dalfampridine were
evaluated between April 2013 and September 2014. Eighty-six
patients had exploitable gait analysis (age: 53.3  9.5; median
EDSS: 5.5 [max: 6.5; min: 4]). Forty-one (47.6%) were classiﬁed as
responders (R) to the dalfampridine after improving their T25FWT of
over 20% and 45 (52.3%) as non-responders (NR). The dalfampridine
improved the spontaneous and supported walking velocity in the 2
groups (P < 0.05). The cadence and stride length improved in the 2
groups independently of the velocity (P < 0.05). On D14, the NR
became asymmetrical (P < 0.001) in spontaneous velocity. There was
an inverse correlation between spontaneous walking velocity to D0
and the % of improvement T25FWT (r = –0.524; P < 0.0001).
Discussion Dalfampridine improves some spatiotemporal gait
parameters in R as in NR but NR become asymmetrical at
spontaneous velocity. The lack of improvement in voluntarymotor
function could explain this asymmetry. Spontaneous walking
speed measured with locometer could be a predictive factor of
response to dalfampridine.
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Objective The aims of this study were to evaluate the effects of
fampridine on verbal ﬂuencies in MS patients and to compare the
supposed cognitive effect with the gait effect.
Design Our studywas a prospectivemonocentric open label trial.
Thirty-one MS patients were included (42% primary progressive
MS, 45% secondarly progressive MS, 13% relapsing-remitting MS)
with a mean EDSS of 5.43. Assessments of verbal phonological and
semantic ﬂuencies were repeated twice (within one week) before
fampridine treatment, and twice after fampridine treatment. Gait
velocity was measured before and after fampridine treatment.
Post-hoc analyses were performed in order to limit the impact of
the practice effect.
Results Verbal ﬂuencies were signiﬁcantly improved by fampri-
dine treatment (P < 0.05). Phonological ﬂuency showed greater
improvement than semantic ﬂuency after fampridine treatment.
No signiﬁcant difference on verbal ﬂuency performance was
observed between gait responders and non-responders groups.
Conclusion The results suggest a speciﬁc cognitive effect of treat-
ment with fampridine. There is an improvement in verbal inﬂuences
mainly phonological, which implies an action on executive functions.
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Background Home care for patients with multiple sclerosis relies
largely on informal caregivers (ICs).
Methods We assessed ICs objective burden (Informal Care Time,
ICT) and ICs subjective burden (Zarit Burden Inventory, ZBI) and
their explanatory factors.
Results ICs (n = 99) were spouses (70%), mean age 52 years,
assisting disabled patients with a mean Expanded Disability Status
Scale (EDSS) of 5.5, with executive dysfunction (mean DysExecutive
Questionnaire [DEX] of 25) and a duration of MS ranging from 1 to
44 years. Objective burden was high (mean ICT = 6.5 hours/day),
mostly consisting of supervision time. Subjective burden was
moderate (mean ZBI = 27.3). Multivariate analyses showed that
both burdens were positively correlated with higher levels of EDSS
and DEX, whereas co-residency and IC’s female gender correlated
with objective burden only and IC’s poor mental health status with
subjective burden only. When considering MS aggressiveness, it
appeared that both burdens were not correlated with a higher
duration of MS but rather increased for patients with severe and
early cognitive dysfunction and for patients classiﬁed as fast
progressors according to the Multiple Sclerosis Severity Scale.
Conclusion MS disability course and IC’s personal situation must
be evaluated to understand the burden process and to implement
adequate interventions in MS.
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Objective To study the risk factors for falls in patients with
multiple sclerosis presenting gait disturbances.
Methods This is a retrospective review of prospectively collected
data from a cohort of MS patients followed for gait disturbances
between April 2013 and June 2014 in the neurological rehabilita-
tion department. The history of falls, trauma, current treatments
and clinical data (disease duration, clinical form, EDSS,motor skills,
spasticity, pain) were collected. Univariate and multivariate
analyzes were performed to predict the risk of falls.
Results One hundred and ninety-six patients (median EDSS: 6;
age: 55 years [9.3])were divided into 2 groups: fallers (n = 92), non-
fallers (n = 103). In our model, taking antidepressants, previous
fractures (upper limbs, spine), sprains of ankles and knees, impaired
visual and brain functions (or mental) of EDSS were predictors of falls
(AUC = 0.73; sensitivity = 0.74; speciﬁcity = 0.59).
Discussion Balance disorders and falls are among the most
disabling symptoms of MS, affecting about 3/4 of patients during
the course of the disease. In our study, 47.1% of patients had falled.
These results are similar to those of Cattaneo et al. [1], (54%) and of
Finlayson et al. [2], (52.2%). If visual disturbances and anti-
depressants have been identiﬁed as risk factors for falling, prior
fracture and sprain were not included in those studies. This could
explain the fear of falling in this population. Investigation of a
history of fracture or sprain is recommended in the pervention of
falls in MS patients with gait disturbances.
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